Skip to Main Content

Paper Details

Reducing cardiovascular risk with immunomodulators: a randomised active comparator trial among patients with rheumatoid arthritis.
Annals of the Rheumatic Diseases
6
2023
F-fluorodeoxyglucose, Patients, RA, TNF, TNFi, arterial inflammation, hydroxychloroquine, methotrexate, patients, rheumatoid arthritis, sulfasalazine, tumour necrosis factor, vascular inflammation, women
Author NameAffiliation
Katherine P LiaoBrigham and Women's Hospital
Paul M RidkerBrigham and Women's Hospital
Zahi A FayadMount Sinai Medical Center
  • 1 - 3

Datasets

Release 1.2